283 related articles for article (PubMed ID: 15902580)
1. Relationship between mirtazapine dose, plasma concentration, response, and side effects in clinical practice.
Grasmäder K; Verwohlt PL; Kühn KU; Frahnert C; Hiemke C; Dragicevic A; von Widdern O; Zobel A; Maier W; Rao ML
Pharmacopsychiatry; 2005 May; 38(3):113-7. PubMed ID: 15902580
[TBL] [Abstract][Full Text] [Related]
2. Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients.
Schüle C; Baghai TC; Eser D; Schwarz M; Bondy B; Rupprecht R
J Psychiatr Res; 2009 Feb; 43(5):538-45. PubMed ID: 18706658
[TBL] [Abstract][Full Text] [Related]
3. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
Behnke K; Søgaard J; Martin S; Bäuml J; Ravindran AV; Agren H; Vester-Blokland ED
J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411
[TBL] [Abstract][Full Text] [Related]
4. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
Blier P; Gobbi G; Turcotte JE; de Montigny C; Boucher N; Hébert C; Debonnel G
Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
[TBL] [Abstract][Full Text] [Related]
5. Mirtazapine naturalistic depression study (in Sweden)--MINDS(S): clinical efficacy and safety.
Wålinder J; Prochazka J; Odén A; Sjödin I; Dahl ML; Ahlner J; Bengtsson F
Hum Psychopharmacol; 2006 Apr; 21(3):151-8. PubMed ID: 16444795
[TBL] [Abstract][Full Text] [Related]
6. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Malhi GS; Ng F; Berk M
Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.
Kim SW; Shin IS; Kim JM; Kim YC; Kim KS; Kim KM; Yang SJ; Yoon JS
Psychiatry Clin Neurosci; 2008 Feb; 62(1):75-83. PubMed ID: 18289144
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study.
Altintoprak AE; Zorlu N; Coskunol H; Akdeniz F; Kitapcioglu G
Hum Psychopharmacol; 2008 Jun; 23(4):313-9. PubMed ID: 18327889
[TBL] [Abstract][Full Text] [Related]
9. Mirtazapine for treatment-resistant depression: a preliminary report.
Wan DD; Kundhur D; Solomons K; Yatham LN; Lam RW
J Psychiatry Neurosci; 2003 Jan; 28(1):55-9. PubMed ID: 12587851
[TBL] [Abstract][Full Text] [Related]
10. Mirtazapine does not influence tetrahydrodeoxycorticosterone levels in depressed patients.
Schüle C; Baghai TC; di Michele F; Eser D; Pasini A; Romeo E; Rupprecht R
World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):308-13. PubMed ID: 20218794
[TBL] [Abstract][Full Text] [Related]
11. Assessment of sexual functioning in depressed patients treated with mirtazapine: a naturalistic 6-month study.
Saiz-Ruiz J; Montes JM; Ibáñez A; Díaz M; Vicente F; Pelegrín C; Viñas R; Arias F; Carrasco JL; Ferrando L
Hum Psychopharmacol; 2005 Aug; 20(6):435-40. PubMed ID: 16106478
[TBL] [Abstract][Full Text] [Related]
12. The effect of mirtazapine in patients with chronic pain and concomitant depression.
Freynhagen R; Muth-Selbach U; Lipfert P; Stevens MF; Zacharowski K; Tölle TR; von Giesen HJ
Curr Med Res Opin; 2006 Feb; 22(2):257-64. PubMed ID: 16466597
[TBL] [Abstract][Full Text] [Related]
13. Mirtazapine-induced manic switch in adolescent unipolar depression.
Goyal N; Sinha VK
Aust N Z J Psychiatry; 2008 Dec; 42(12):1070-1. PubMed ID: 19031640
[No Abstract] [Full Text] [Related]
14. Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study.
Varia I; Venkataraman S; Hellegers C; Gersing K; Doraiswamy PM
Psychopharmacol Bull; 2007; 40(1):47-56. PubMed ID: 17285095
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions?
Müller MJ; Dragicevic A; Fric M; Gaertner I; Grasmäder K; Härtter S; Hermann E; Kuss HJ; Laux G; Oehl W; Rao ML; Rollmann N; Weigmann H; Weber-Labonte M; Hiemke C
Pharmacopsychiatry; 2003 May; 36(3):98-104. PubMed ID: 12806567
[TBL] [Abstract][Full Text] [Related]
16. Predictors of therapeutic effects in amitriptyline treatment--1. Plasma drug levels.
Franke L; Schewe HJ; Uebelhack R; Müller-Oerlinghausen B
Pharmacopsychiatry; 2003 Jul; 36(4):134-42. PubMed ID: 12905099
[TBL] [Abstract][Full Text] [Related]
17. A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.
Cruickshank CC; Montebello ME; Dyer KR; Quigley A; Blaszczyk J; Tomkins S; Shand D
Drug Alcohol Rev; 2008 May; 27(3):326-33. PubMed ID: 18368615
[TBL] [Abstract][Full Text] [Related]
18. Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness.
Hannan N; Hamzah Z; Akinpeloye HO; Meagher D
J Psychopharmacol; 2007 Mar; 21(2):161-4. PubMed ID: 17329295
[TBL] [Abstract][Full Text] [Related]
19. Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: a multicentre, open label study.
Yoon SJ; Pae CU; Kim DJ; Namkoong K; Lee E; Oh DY; Lee YS; Shin DH; Jeong YC; Kim JH; Choi SB; Hwang IB; Shin YC; Cho SN; Lee HK; Lee CT
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1196-201. PubMed ID: 16624467
[TBL] [Abstract][Full Text] [Related]
20. Mirtazapine acutely inhibits salivary cortisol concentrations in depressed patients.
Laakmann G; Hennig J; Baghai T; Schüle C
Ann N Y Acad Sci; 2004 Dec; 1032():279-82. PubMed ID: 15677428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]